EBS
Emergent Biosolutions Inc
NYSE: EBS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.23
+3.00% today
Updated 2026-04-30
Market cap
$414.70M
P/E ratio
8.63
P/S ratio
0.56x
EPS (TTM)
$0.93
Dividend yield
—
52W range
$5 – $14
Volume
0.9M
Emergent Biosolutions Inc (EBS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.06M | $55.45M | $7.32M | $30.51M | $99.54M | $14.59M | $39.64M | $96.97M | $112.32M | $44.46M | $53.49M | $208.14M | $41.80M | $188.00M | $536.90M | $321.10M | $-34.10M | $-206.30M | $58.70M | $170.60M |
| Capital expenditures | $41.23M | $43.97M | $20.81M | $33.29M | $22.10M | $54.03M | $53.84M | $42.02M | $30.67M | $44.81M | $76.26M | $54.83M | $72.10M | $86.90M | $141.90M | $225.00M | $115.80M | $51.60M | $22.90M | $13.80M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $723000.00 | $24000.00 | $2.51M | $5.01M | $7.06M | $10.74M | $11.12M | $11.24M | $12.83M | $15.85M | $18.48M | $15.21M | $23.20M | $26.70M | $51.80M | $42.40M | $45.10M | $23.10M | $18.00M | $16.20M |
| Free cash flow | $-45.29M | $11.48M | $-13.50M | $-2.78M | $77.44M | $-39.43M | $-14.20M | $54.95M | $81.64M | $-353000.00 | $-22.77M | $153.31M | $-30.30M | $101.10M | $395.00M | $96.10M | $-149.90M | $-257.90M | $35.80M | $156.80M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $46.20M | $0.00 | $0.00 | $0.00 | $45.00M | $0.00 | $0.00 | $0.00 | — | $799999.00 | $17.80M | $15.90M | — | $5.00M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $37.67M | — | $32.30M | $-41.28M | $-93.22M | $-66.90M | $55.20M | $454.50M | $-44.90M | $65.80M | — | — | — |